Deerland Enzymes launches ‘cutting-edge’ antioxidant formula

13-Sep-2011 - Last updated on 22-Sep-2011 at 15:49 GMT

Georgia-based Deerland Enzymes has launched a ‘cutting-edge’ antioxidant formulation said to combine antioxidant compounds and antioxidant enzymes for dietary supplements.

The ThioZyme Formula has been developed by Thione International, Inc., and its founder Theodore Hersh, MD, and is reported to contain cellular antioxidants with antioxidant enzymes. The body’s antioxidant enzymes include the superoxide dismutase (SOD), catalase and glutathione peroxidase.

The formula is claimed to offer twice the antioxidant capacity of glutathione, as described by Oxygen Radical Absorbance Capacity (ORAC).

A spokesperson for Deerland Enzymes told NutraIngredients-USA that the formulation contains a combination of lactoperoxidase, SOD, catalase along with select amino acids, vitamins and anti-oxidants.

Forms

Antioxidant enzymes can be susceptible to the damaging environment of the stomach. As such, the formulation can be offered as an “enteric coated vegetable based hard shell capsule, a delayed release capsule and for those customers who prefer, strict guidance to consumers that they take the product during a meal, which based on the acidity change should not be an issue”, added the spokesperson.

The formulation – only available for supplements – is powder based, said the company, and is customizable. “However, any changes to meet specific customer performance needs / requests will first be scrutinized in our lab to make certain there are no interaction issues and then for regulatory compliance,” added the spokesperson.

Oxidative stress

Oxygen-breathing organisms naturally produce reactive oxygen species (ROS), which play an important role in a range of functions, including cell signalling. However, over production of these ROS from smoking, pollution, sunlight, high intensity exercise, or simply ageing, may overwhelm the body’s antioxidant defences and lead to oxidative stress.

Oxidative stress has been linked to an increased risk of various diseases including cancer, Alzheimer's, and cardiovascular disease.

“The cutting-edge ThioZyme formula, backed by state-of-the-art scientific support, will be unique in the marketplace,” said Dr Hersh.

“Its benefits to the consumer are numerous and Thione is excited to begin its alliance with Deerland with this particular joint product launch,”

Scott Ravech, CEO of Deerland Enzymes added: “While our plan has always been to launch several new products from the Deerland/Thione alliance this year, I am grateful to Dr. Theodore Hersh and the Deerland R&D team for a phenomenal first product launch.”